Kwon Paul 4
4 · Menlo Therapeutics Inc. · Filed Dec 12, 2018
Insider Transaction Report
Form 4
Kwon Paul
Chief Scientific Officer
Transactions
- Award
Stock Option
2018-12-10+64,000→ 64,000 totalExercise: $5.51Exp: 2028-12-10→ Common Stock (64,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly.